FDA Advisory Panel Votes Against Covid-19 Booster Shots for General Population but Endorses It for Some Groups

A Food and Drug Administration advisory panel offered a limited endorsement of booster shots of the Covid-19 vaccinefrom Pfizer Inc. and BioNTech SE , recommending shots for adults 65 years and older and those at high risk of severe disease, but falling short of the broader recommendation the Biden administration had planned for.

The outside panel’s action comes as the dangerous Delta variant continues to spread in the U.S. and federal health officials hope that additional doses will sustain protection in people who have been previously vaccinated.


Read More   Lebanon central bank starts giving credit for fuel imports at weaker rate

This website uses cookies. By continuing to use this site, you accept our use of cookies.